Company: SCLXW
Filing Date: 2025-08-14
Form Type: 424B3
Source: 0000950170-25-108226
Chunk: 87

Company: Scilex Holding Co
Filing Date: 2025-08-14
Form: 424B3
Chunk 87
---
 Purchase Agreement, $0.1 million for the purchased revenue liability pursuant to the Gloperba-Elyxyb Royalty Purchase Agreement and $4.2 million in change in fair value of the Tranche B Notes. The loss recognized during the three months ended June 30, 2024 was attributed to the Oramed Note and the FSF Deposit. The Oramed Note was issued in September 2023 in the principal amount of $101.9 million, of which the principal amount of $26.5 million remained outstanding as of June 30, 2025. The FSF Deposit was received in June 2024 in the principal amount of $10.0 million, and was satisfied in November 2024 by the delivery of the Additional Product to Endeavor. The Tranche B Notes were issued in October 2024 in the principal amount of $50.0 million, of which the principal amount of $30.7 million remained outstanding as of June 30, 2025.

Interest Expense, Net

Interest expense, net for the three months ended June 30, 2025 and 2024 was $2.7 million and $0.6 million, respectively. Interest expense of $2.7 million for the three months ended June 30, 2025 primarily consists of the interest on the balances due for government and commercial rebate programs. Interest expense of $0.6 million for the three months ended June 30, 2024 consists of the interest related to the Revolving Facility.

Results of Operations for the Six Months Ended June 30, 2025 and 2024

The following tables summarize our results of operations for the six months ended June 30, 2025 and 2024 (in thousands):

<div align='center'>51</div>

| Statements of Operations Data:                         |     | Six Months Ended June 30, 
 2025                      |         |   |     | 2024 |         |   |     | Changes |         |   |
|:-------------------------------------------------------|:----|:--------------------------|--------:|:--|:----|:-----|--------:|:--|:----|:--------|--------:|:--|
| Net revenue                                            |     | $                         |  14,900 |   |     | $    |  27,254 |   |     | $       | (12,354 | ) |
| Net operating costs and expenses:                      |     |